
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$311.7m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.75
7D
7.9%
1Y
650.0%
Neuren Pharmaceuticals
Market Cap: AU$2.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.48
7D
6.2%
1Y
1.1%